{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T15:46:31Z","timestamp":1749829591260},"reference-count":17,"publisher":"Japan Neurosurgical Society","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.2176\/jns-nmc.2022-0227","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T22:14:08Z","timestamp":1679609648000},"page":"67-73","source":"Crossref","is-referenced-by-count":1,"title":["A Unique Case of Intracranial Amelanotic Melanoma with BRAF V600E Mutation Successfully Treated via Molecular-targeted Therapy"],"prefix":"10.2176","volume":"10","author":[{"given":"Juntaro","family":"FUJITA","sequence":"first","affiliation":[{"name":"Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"TOMITA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital"},{"name":"Department of Neurological Surgery, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"ICHIMURA","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"YAMASAKI","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"NISHIGAKI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"NITTA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"INOUE","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"SOTOME","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"KIDANI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"MURAOKA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"HIROTSUNE","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"NISHINO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Anonymous: Brain Tumor Registry of Japan (2005-2008). <i>Neurol Med Chir (Tokyo)<\/i> 57: 9-102, 2017","DOI":"10.2176\/nmc.sup.2017-0001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Sloan AE, Nock CJ, Einstein DB: Diagnosis and treatment of melanoma brain metastasis: a literature review. <i>Cancer Control<\/i> 16: 248-255, 2009","DOI":"10.1177\/107327480901600307"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Sperduto PW, Jiang W, Brown PD, et al.: Estimating survival in melanoma patients with brain metastases: an update of the graded prognostic assessment for melanoma using molecular markers (melanoma-molGPA). <i>Int J Radiat Oncol Biol Phys<\/i> 99: 812-816, 2017","DOI":"10.1016\/j.ijrobp.2017.06.2454"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Saiag P, Robert C, Grob JJ, et al.: Efficacy, safety and factors associated with disease progression in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: an open label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib. <i>Eur J Cancer<\/i> 154: 57-65, 2021","DOI":"10.1016\/j.ejca.2021.05.031"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Jaimes N, Braun RP, Thomas L, Marghoob AA: Clinical and dermoscopic characteristics of amelanotic melanomas that are not of the nodular subtype. <i>J Eur Acad Dermatol Venereol<\/i> 26: 591-596, 2012","DOI":"10.1111\/j.1468-3083.2011.04122.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Flaherty KT, Hodi FS, Fisher DE: From genes to drugs: targeted strategies for melanoma. <i>Nat Rev Cancer<\/i> 12: 349-361, 2012","DOI":"10.1038\/nrc3218"},{"key":"7","unstructured":"7) Alqathama A: BRAF in malignant melanoma progression and metastasis: potentials and challenges. <i>Am J Cancer Res<\/i> 10: 1103-1114, 2020"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Davies MA, Saiag P, Robert C, et al.: Dabrafenib plus trametinib in patients with BRAF (V600) -mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial. <i>Lancet Oncol<\/i> 18: 863-873, 2017","DOI":"10.1016\/S1470-2045(17)30429-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Charifa A, Zhang X: Morphologic and immunohistochemical characteristics of anorectal melanoma. <i>Int J Surg Pathol<\/i> 26: 725-729, 2018","DOI":"10.1177\/1066896918773177"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Lohman ME, Steen AJ, Grekin RC, North JP: The utility of PRAME staining in identifying malignant transformation of melanocytic nevi. <i>J Cutan Pathol<\/i> 48: 856-862, 2021","DOI":"10.1111\/cup.13958"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Ito T, Tanaka Y, Murata M, Kaku-Ito Y, Furue K, Furue M: BRAF Heterogeneity in Melanoma. <i>Curr Treat Options Oncol<\/i> 22: 20, 2021","DOI":"10.1007\/s11864-021-00818-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Massi D, Pinzani P, Simi L, et al.: BRAF and KIT somatic mutations are present in amelanotic melanoma. <i>Melanoma Res<\/i> 23: 414-419, 2013","DOI":"10.1097\/CMR.0b013e32836477d4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Smith AB, Rushing EJ, Smirniotopoulos JG: Pigmented lesions of the central nervous system: radiologic-pathologic correlation. <i>Radiographics<\/i> 29: 1503-1524, 2009","DOI":"10.1148\/rg.295095109"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Cemil B, Emmez H, Oztanir N, Tokgoz N, Dogulu F: A cystic amelanotic melanoma metastasis to the brain: case report. <i>Neurocirugia (Astur)<\/i> 19: 365-367, 2008","DOI":"10.1016\/S1130-1473(08)70225-2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Isiklar I, Leeds NE, Fuller GN, Kumar AJ: Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content. <i>AJR Am J Roentgenol<\/i> 165: 1503-1512, 1995","DOI":"10.2214\/ajr.165.6.7484597"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Ogawa R, Aoki R, Hyakusoku H: A rare case of intracranial metastatic amelanotic melanoma with cyst. <i>J Clin Pathol<\/i> 56: 548-551, 2003","DOI":"10.1136\/jcp.56.7.548"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Izikson L, Sober AJ, Mihm MC Jr, Zembowicz A: Prevalence of melanoma clinically resembling seborrheic keratosis: analysis of 9204 cases. <i>Arch Dermatol<\/i> 138: 1562-1566, 2002","DOI":"10.1001\/archderm.138.12.1562"}],"container-title":["NMC Case Report Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/10\/0\/10_2022-0227\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:38:30Z","timestamp":1715315910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/10\/0\/10_2022-0227\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,31]]},"references-count":17,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2022-0227","relation":{},"ISSN":["2188-4226"],"issn-type":[{"value":"2188-4226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,31]]},"article-number":"2022-0227"}}